Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
CUE — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

9.44

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

1.76

EPS This/Next Y

-2.81

Price

27.22

Target Price

115

Analyst Recom

1

Performance Q

-24.1

Upside

-365.1%

Beta

2.46

Ticker: CUE



19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13CUE30.610.130.021548
2026-07-14CUE31.650.130.021548
2026-07-15CUE28.380.130.021548
2026-07-16CUE27.740.130.021548
2026-07-17CUE31.390.130.001530
2026-07-20CUE30.350.130.001530
2026-07-21CUE33.720.130.001530
2026-07-22CUE34.160.130.001530
2026-07-23CUE33.20.130.001530
2026-07-24CUE32.320.390.00437
2026-07-27CUE32.270.390.00437
2026-07-28CUE30.750.390.00437
2026-07-29CUE28.270.390.00437
2026-07-30CUE30.430.390.00437
2026-07-31CUE27.110.390.00437
2026-08-03CUE27.42N/AN/A0
2026-08-04CUE26.87N/AN/A0
2026-08-05CUE26.31N/AN/A0
2026-08-07CUE27.2N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13CUE31.00- - -6.64
2026-07-14CUE31.38- - -6.64
2026-07-15CUE28.50- - -6.64
2026-07-16CUE27.49- - -6.64
2026-07-17CUE31.23- - -6.64
2026-07-20CUE30.64- - -6.64
2026-07-21CUE33.69- - -6.64
2026-07-22CUE34.33- - -6.64
2026-07-23CUE33.33- - -6.64
2026-07-24CUE32.26- - -6.64
2026-07-27CUE32.47- - -6.64
2026-07-28CUE30.28- - -6.64
2026-07-29CUE28.02- - -6.64
2026-07-30CUE30.51- - -6.64
2026-07-31CUE27.31- - -6.64
2026-08-03CUE26.85- - -6.64
2026-08-04CUE26.85- - -6.64
2026-08-05CUE26.56- - -6.64
2026-08-06CUE27.02- - -6.64
2026-08-07CUE27.22- - -6.64
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13CUE0.00-1.087.89
2026-07-14CUE0.00-1.087.89
2026-07-15CUE0.00-1.087.89
2026-07-16CUE0.00-1.089.06
2026-07-17CUE0.00-1.089.06
2026-07-20CUE0.00-1.089.06
2026-07-21CUE0.00-1.089.14
2026-07-22CUE0.00-1.089.14
2026-07-23CUE0.00-1.089.14
2026-07-24CUE0.00-1.089.14
2026-07-27CUE0.004.419.44
2026-07-28CUE0.004.419.44
2026-07-29CUE0.004.419.44
2026-07-30CUE0.004.419.44
2026-07-31CUE0.004.419.44
2026-08-03CUE0.002.879.44
2026-08-04CUE0.002.879.44
2026-08-05CUE0.002.879.44
2026-08-06CUE0.002.879.44
2026-08-07CUE0.002.879.44
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

-1.69

Avg. EPS Est. Next Quarter

-1.91

Insider Transactions

Institutional Transactions

2.87

Beta

2.46

Average Sales Estimate Current Quarter

3

Average Sales Estimate Next Quarter

2

Fair Value

Quality Score

26

Growth Score

36

Sentiment Score

40

Actual DrawDown %

95.1

Max Drawdown 5-Year %

-99

Target Price

115

P/E

Forward P/E

PEG

P/S

3.48

P/B

4.09

P/Free Cash Flow

EPS

-5.53

Average EPS Est. Cur. Y​

-6.64

EPS Next Y. (Est.)

-9.45

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-59.65

Relative Volume

0.42

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

10.8

EPS 1 30Days Diff

10.76

EBIT Estimation

◆ CUE Healthcare
$27.12
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
18/25
Volume
11/15
Valuation
10/20
TP/AR
6/10
Options
0/10
RSI
44.3
Range 1M
9.5%
Sup Dist
3.4%
🚀
Momentum Growth
Ride accelerating trends
N/A
29 /100
WEAK
Momentum
2/25
Growth
16/30
Estimates
6/20
Inst/Vol
5/15
Options
0/10
EPS Yr
21%
EPS NY
-42.3%
52W%
54.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +324% upside
Quality
6/30
Valuation
16/30
Growth
13/25
Stability
7/10
LT Trend
3/5
Upside
+324%
Quality
26
Click a card to see score breakdown Full Analysis →
CUE — P/E HistoricalBiotechnology
Cue Biopharma, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 29
Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is advancing towards Phase 1 development to regulate inflammation and drive Treg-mediated tolerance. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.
CUE

Latest News

—
Caricamento notizie per CUE…
stock quote shares CUE – Cue Biopharma Inc Stock Price stock today
news today CUE – Cue Biopharma Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch CUE – Cue Biopharma Inc yahoo finance google finance
stock history CUE – Cue Biopharma Inc invest stock market
stock prices CUE premarket after hours
ticker CUE fair value insiders trading